| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-11 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.22 | 6e-11 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.21 | 9e-11 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-10 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-10 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-10 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-10 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-10 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.21 | 5e-10 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-10 |